Merck KGaA

Industry / private company


Location: Darmstadt, Germany (DE) DE

ISNI: 0000000106727022

ROR: https://ror.org/04b2dty93

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Impact of Payload Hydrophobicity on the Stability of Antibody-Drug Conjugates (2018) Bücheler J, Winzer M, Tonillo J, Weber C, Gieseler H Journal article, Original article Comparative study and simulation of tumor cell inactivation by microwave and conventional heating (2018) Rosin A, Hader M, Drescher C, Suntinger M, Gerdes T, Willert-Porada M, Gaipl U, Frey B Journal article Structural Effects of Intra-Articular Sprifermin in Symptomatic Radiographic Knee Osteoarthritis: A Post-Hoc Analysis of Cartilage Morphology over the 2-Year Treatment-Period of a 5-Year Randomized, Placebo-Controlled, Phase II Study (2018) Guermazi A, Kraines J, Aydemir A, Wax S, Crema M, Hochberg MC, Roemer F Conference contribution Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe (2017) Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pfoehler C, Kellner I, et al. Journal article A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study (2017) Harbeck N, Saupe S, Jaeger E, Schmidt M, Kreienberg R, Mueller L, Otremba BJ, et al. Journal article Liquid silver tris(perfluoroethyl)trifluorophosphate salts as new media for propene/propane separation (2016) Pliquett D, Schulz P, Heinemann FW, Bause A, Wasserscheid P Journal article Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Comparison of radiographic joint space width and magnetic resonance imaging for prediction of knee replacement: A longitudinal case-control study from the Osteoarthritis Initiative (2016) Eckstein F, Boudreau R, Wang Z, Hannon MJ, Duryea J, Wirth W, Cotofana S, et al. Journal article Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers (2016) Gross S, Lennerz V, Gallerani E, Mach N, Boehm S, Hess D, Von Boehmer L, et al. Journal article
1 2 3 4 5